U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07056777) titled 'Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer' on June 29.

Brief Summary: This is a multicenter, open-label phase Ib/IIa clinical study conducted in China, aimed at evaluating the safety tolerance, efficacy, pharmacokinetic (PK) characteristics, and immunogenicity of DR30206 in combination with standard treatment regimens for advanced or metastatic gastrointestinal tumors.

Study Start Date: March 25

Study Type: INTERVENTIONAL

Condition: Gastrointestinal Cancer

Intervention: DRUG: DR30206

Subjects receive DR30206 intravenously

DRUG: O...